Since the activation of TRPV4 channels has also been associated with cardiac fibrosis [80,81,90], the potential therapeutic benefits of TRPV4 channel inhibition to attenuate calcium overloading and myocardial fibrosis warrant future study. The gene discussed is TRPV4; the disease is Myocardial fibrosis.